share share      print print

Complete list of publications


 


2013 |  2012 |  2011 |  2010 |  2009 |  2008 |  2007 |  2005 |  2004 |  2003 |  2002 |  2001 |  2000 |  1999 |  1998 |  1997 |  1996 |  1995 |  1994 |  1991 |  1990 |  1988 |  1987 |  1986 |  1985 |  1983 |  Thèses (doctorat) | 
 

2013
Barsic B., Dickerman S., Krajinovic V., Pappas P., Altclas J., Carosi G., Casabé J.H., Chu V.H., Delahaye F., Edathodu J. et al., 2013. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clinical Infectious Diseases 56(2) pp. 209-217. [DOI] [Web of Science] [Pubmed]
Chambers S.T., Murdoch D., Morris A., Holland D., Pappas P., Almela M., Fernández-Hidalgo N., Almirante B., Bouza E., Forno D. et al., 2013. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One 8(5) pp. e63181. [DOI] [Web of Science] [Pubmed]
Chirouze C., Athan E., Alla F., Chu V.H., Ralph Corey G., Selton-Suty C., Erpelding M.L., Miro J.M., Olaison L., Hoen B. et al., 2013. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clinical Microbiology and Infection 19(12) pp. 1140-1147. [DOI] [Web of Science] [Pubmed]
Guignard B., Vouillamoz J., Giddey M., Moreillon P., 2013. A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus. European Journal of Clinical Microbiology and Infectious Diseases 32(7) pp. 899-907. [DOI] [Web of Science] [Pubmed]
Lalani T., Chu V.H., Park L.P., Cecchi E., Corey G.R., Durante-Mangoni E., Fowler V.G., Gordon D., Grossi P., Hannan M. et al., 2013. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Internal Medicine 173(16) pp. 1495-1504. [DOI] [Web of Science] [Pubmed]
Oechslin F., Daraspe J., Giddey M., Moreillon P., Resch G., 2013. In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrobial Agents and Chemotherapy 57(12) pp. 6276-6283. [DOI] [Web of Science] [Pubmed]
Resch G., François P., Morisset D., Stojanov M., Bonetti E.J., Schrenzel J., Sakwinska O., Moreillon P., 2013. Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome. PLoS One 8(3) pp. e58187. [DOI] [Web of Science] [Pubmed]
Stojanov M., Sakwinska O., Moreillon P., 2013. Expression of SCCmec cassette chromosome recombinases in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy 68(4) pp. 749-757. [DOI] [Web of Science] [Pubmed]
Veloso T.R., Chaouch A., Roger T., Giddey M., Vouillamoz J., Majcherczyk P., Que Y.A., Rousson V., Moreillon P., Entenza J.M., 2013. Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infection and Immunity 81(3) pp. 697-703. [DOI] [Web of Science] [Pubmed]
Veloso T.R., Zbinden A., Andreoni F., Giddey M., Vouillamoz J., Moreillon P., Zinkernagel A.S., Entenza J.M., 2013. Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis. International Journal of Medical Microbiology 303(8) pp. 498-504. [DOI] [Web of Science] [Pubmed]
Vouillamoz J., Entenza J.M., Giddey M., Fischetti V.A., Moreillon P., Resch G., 2013. Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. International Journal of Antimicrobial Agents 42(5) pp. 416-421. [DOI] [Web of Science] [Pubmed]
2012
Athan E., Chu V.H., Tattevin P., Selton-Suty C., Jones P., Naber C., Miró J.M., Ninot S., Fernández-Hidalgo N., Durante-Mangoni E. et al., 2012. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. Journal of the American Medical Association 307(16) pp. 1727-1735. [DOI] [Pubmed]
Dengler V., Meier P.S., Heusser R., Kupferschmied P., Fazekas J., Friebe S., Staufer S.B., Majcherczyk P.A., Moreillon P., Berger-Bächi B. et al., 2012. Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response. FEMS Microbiology Letters 333(2) pp. 109-120. [DOI] [Web of Science] [Pubmed]
Miró J.M., Entenza J.M., Del Río A., Velasco M., Castañeda X., Garcia de la Mària C., Giddey M., Armero Y., Pericàs J.M., Cervera C. et al., 2012. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 56(8) pp. 4511-4515. [DOI] [Web of Science] [Pubmed]
Oppliger Anne, Moreillon Philippe, Charrière Nicole, Giddey Marlyse, Morisset Delphine, Sakwinska Olga, 2012. Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs. Applied and Environmental Microbiology 78(22) pp. 8010-8014. [DOI] [Web of Science] [Pubmed]
Rosin C., Bernsmeier C., Entenza J.M., Moreillon P., Frei R., Weisser M., Flückiger U., 2012. Daptomycin for highly resistant Enterococcus faecium infection. Swiss Medical Weekly 142 pp. w13603. [DOI] [Web of Science] [Pubmed]
Waridel P., Ythier M., Gfeller A., Moreillon P., Quadroni M., 2012. Evidence for a new post-translational modification in Staphylococcus aureus: Hydroxymethylation of asparagine and glutamine. Journal of Proteomics 75(6) pp. 1742-1751. [DOI] [Pubmed]
Ythier M., Resch G., Waridel P., Panchaud A., Gfeller A., Majcherczyk P., Quadroni M., Moreillon P., 2012. Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. Molecular and Cellular Proteomics 11(11) pp. 1123-1139. [DOI] [Web of Science] [Pubmed]
2011
Danne C., Entenza J.M., Mallet A., Briandet R., Débarbouillé M., Nato F., Glaser P., Jouvion G., Moreillon P., Trieu-Cuot P. et al., 2011. Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. Journal of Infectious Diseases 204(12) pp. 1960-1970. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Majcherczyk P., Moreillon P., 2011. In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(9) pp. 3977-3984. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(1) pp. 385-387. [DOI] [Web of Science] [Pubmed]
Kiefer T., Park L., Tribouilloy C., Cortes C., Casillo R., Chu V., Delahaye F., Durante-Mangoni E., Edathodu J., Falces C. et al., 2011. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306(20) pp. 2239-2247. [DOI] [Web of Science] [Pubmed]
Nienaber J.J., Sharma Kuinkel B.K., Clarke-Pearson M., Lamlertthon S., Park L., Rude T.H., Barriere S., Woods C.W., Chu V.H., Marín M. et al., 2011. Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. Journal of Infectious Diseases 204(5) pp. 704-713. [DOI] [Web of Science] [Pubmed]
Pea F., Cojutti P., Petrosillo N., Furlanut M., Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(9) pp. 4496; author reply 4496-4496; author reply 4497. [DOI] [Pubmed]
Que Y.A., Moreillon P., 2011. Infective endocarditis. Nature Reviews. Cardiology 8(6) pp. 322-336. [DOI] [Web of Science] [Pubmed]
Resch G., Moreillon P., Fischetti V.A., 2011. A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance. International Journal of Antimicrobial Agents 38(6) pp. 516-521. [DOI] [Web of Science] [Pubmed]
Resch G., Moreillon P., Fischetti V.A., 2011. PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express 1 p. 29. [DOI] [Pubmed]
Sakwinska O., Giddey M., Moreillon M., Morisset D., Waldvogel A., Moreillon P., 2011. Staphylococcus aureus host range and human-bovine host shift. Applied and Environmental Microbiology 77(17) pp. 5908-5915. [DOI] [Web of Science] [Pubmed]
Sakwinska O., Morisset D., Madec J.Y., Waldvogel A., Moreillon P., Haenni M., 2011. Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing Swiss and French isolates from the Rhône Valley. Applied and Environmental Microbiology 77(10) pp. 3428-3432. [DOI] [Web of Science] [Pubmed]
Veloso T.R., Amiguet M., Rousson V., Giddey M., Vouillamoz J., Moreillon P., Entenza J.M., 2011. Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infection and Immunity 79(5) pp. 2006-2011. [DOI] [Web of Science] [Pubmed]
2010
Bizzini A., Entenza J.M., Michielin O., Arnold I., Erni B., Moreillon P., 2010. A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii. Antimicrobial Agents and Chemotherapy 54(1) pp. 259-266. [DOI] [Web of Science] [Pubmed]
Buck A.W., Fowler V.G., Yongsunthon R., Liu J., DiBartola A.C., Que Y.A., Moreillon P., Lower S.K., 2010. Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis. Langmuir 26(13) pp. 10764-10770. [DOI] [Web of Science] [Pubmed]
Chapuis T.M., Giannoni E., Majcherczyk P.A., Chioléro R., Schaller M.D., Berger M.M., Bolay S., Décosterd L.A., Bugnon D., Moreillon P., 2010. Prospective monitoring of cefepime in intensive care unit adult patients. Critical Care 14(2) pp. R51. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Giddey M., Vouillamoz J., Moreillon P., 2010. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. International Journal of Antimicrobial Agents 35(5) pp. 451-456. [DOI] [Web of Science] [Pubmed]
Haenni M., Galofaro L., Ythier M., Giddey M., Majcherczyk P., Moreillon P., Madec J.Y., 2010. Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin. Antimicrobial Agents and Chemotherapy 54(3) pp. 1140-1145. [DOI] [Web of Science] [Pubmed]
Moreillon P., 2010. Endocarditis and endarteritis. pp. 514-528 in Cohen J., Opal S.M., Powderly W.G. (eds.) Infectious diseases. 3rd edition, Mosby, Edinburgh.
Que Y.A., Moreillon P., 2010. Staphylococcus aureus (Including Staphylococcal Toxic Shock). pp. 2543-2578 in Mandell G.L., Bennett J.E., Dolin R. (eds.) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed, Churchill Livingstone Elsevier, Philadelphia.
Sakwinska O., Blanc D.S., Lazor-Blanchet C., Moreillon M., Giddey M., Moreillon P., 2010. Ecological temporal stability of Staphylococcus aureus nasal carriage. Journal of Clinical Microbiology 48(8) pp. 2724-2728. [DOI] [Web of Science] [Pubmed]
Sakwinska Olga, Oppliger Anne, Giddey Marlyse, Morisset Delphine, Moreillon Martine, Waldvogel Andreas, Moreillon Philippe, 2010. MRSA ST398 in Switzerland : not only colonization of pigs and pig workers but also cow mastitis. pp. ENA-1 in Immunology and Cancer, CHUV Research Day, January 28, 2010. CHUV Research Day . Université de Lausanne, Faculté de biologie et de médecine, Lausanne. [url editor site]
Ythier M., Entenza J.M., Bille J., Vandenesch F., Bes M., Moreillon P., Sakwinska O., 2010. Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus. Infection and Immunity 78(4) pp. 1711-1716. [DOI] [Web of Science] [Pubmed]
2009
Benito N., Miró J.M., de Lazzari E., Cabell C.H., del Río A., Altclas J., Commerford P., Delahaye F., Dragulescu S., Giamarellou H. et al., 2009. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Annals of Internal Medicine 150(9) pp. 586-594. [Web of Science] [Pubmed]
del Rio A., Cervera C., Moreno A., Moreillon P., Miró J.M., 2009. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clinical Infectious Diseases 48 Suppl 4 pp. S246-S253. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Haldimann A., Giddey M., Lociuro S., Hawser S., Moreillon P., 2009. Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model. Antimicrobial Agents and Chemotherapy 53(9) pp. 3635-3641. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Moreillon P., 2009. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. International Journal of Antimicrobial Agents 34(1) pp. 8.e1-8.e9. [DOI] [Web of Science] [Pubmed]
Heying R., van de Gevel J., Que Y.A., Piroth L., Moreillon P., Beekhuizen H., 2009. Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells. Thrombosis and Haemostasis 101(3) pp. 495-504. [DOI] [Web of Science] [Pubmed]
Murdoch D.R., Corey G.R., Hoen B., Miró J.M., Fowler V.G., Bayer A.S., Karchmer A.W., Olaison L., Pappas P.A., Moreillon P. et al., 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine 169(5) pp. 463-473. [DOI] [Web of Science] [Pubmed]
Naber C.K., Baddour L.M., Giamarellos-Bourboulis E.J., Gould I.M., Herrmann M., Hoen B., Karchmer A.W., Kobayashi Y., Kozlov R.S., Lew D. et al., 2009. Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clinical infectious diseases 48 Suppl 4 pp. S260-S270. [DOI] [Web of Science] [Pubmed]
Panchaud A., Guy L., Collyn F., Haenni M., Nakata M., Podbielski A., Moreillon P., Roten C.A., 2009. M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island. BMC genomics 10 p. 198. [Document] [DOI] [Web of Science] [Pubmed]
Sakwinska O., Kuhn G., Balmelli C., Francioli P., Giddey M., Perreten V., Riesen A., Zysset F., Blanc D.S., Moreillon P., 2009. Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans. Applied and Environmental Microbiology 75(1) pp. 175-183. [DOI] [Web of Science] [Pubmed]
Sakwinska Olga, Oppliger Anne, Giddey Marlyse, Moreillon Martine, Waldvogel Andreas, Moreillon Philippe, 2009. Transmission of MRSA and MSSA between humans and farm animals. pp. P050, 110 in Microbes rule the world : 68th Annual Assembly of the SSM, Amphipôle, University of Lausanne, 4-5 June, 2009. Swiss Society for Microbiology. [url editor site]
Sakwinska Olga, Oppliger Anne, Giddey Marlyse, Morisset Delphine, Moreillon Martine, Waldvogel Andreas, Moreillon Philippe, 2009. MRSA ST398 in Switzerland : not only colonization of pigs and pig workers but also cow mastitis. pp. 18B, 34 in Methicillin-Resistant Staphylococci in Animals : veterinary and public health implications : ASM Conferences, September 22-25, 2009, London, England. American Society for Microbiology, Washington.
2008
Durante-Mangoni E., Bradley S., Selton-Suty C., Tripodi M.F., Barsic B., Bouza E., Cabell C.H., Ramos A.I., Fowler V., Hoen B. et al., 2008. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Archives of Internal Medicine 168(19) pp. 2095-2103. [DOI] [Web of Science] [Pubmed]
Haenni M., Moreillon P., 2008. Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory. Antimicrobial Agents and Chemotherapy 52(1) pp. 337-339. [DOI] [Web of Science] [Pubmed]
Majcherczyk P.A., Barblan J.L., Moreillon P., Entenza J.M., 2008. Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis. Microbial pathogenesis 45(5-6) pp. 408-414. [DOI] [Web of Science] [Pubmed]
Moreillon P., 2008. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Clinical Microbiology and Infection 14(Suppl. 3) pp. 32-41. [DOI] [Web of Science] [Pubmed]
Panchaud A., Affolter M., Moreillon P., Kussmann M., 2008. Experimental and computational approaches to quantitative proteomics: status quo and outlook. Journal of Proteomics 71(1) pp. 19-33. [DOI] [Web of Science] [Pubmed]
Panchaud A., Hansson J., Affolter M., Bel R. R., Piu S., Moreillon P., Kussmann M., 2008. ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups. Molecular and Cellular Proteomics 7(4) pp. 800-812. [DOI] [Web of Science] [Pubmed]
Piroth L., Que Y.A., Widmer E., Panchaud A., Piu S., Entenza J.M., Moreillon P., 2008. The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infection and Immunity 76(8) pp. 3824-3831. [DOI] [Web of Science] [Pubmed]
Vankerckhoven V., Huys G., Vancanneyt M., Vael C., Klare I., Romond M.B., Entenza J.M., Moreillon P., Wind R.D., Knol J. et al., 2008. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends in Food Science and Technology 19(2) pp. 102-114. [DOI] [Web of Science]
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2008. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. Journal of Antimicrobial Chemotherapy 61(2) pp. 371-374. [DOI] [Web of Science] [Pubmed]
2007
Bizzini A., Entenza J.M., Moreillon P., 2007. Loss of penicillin tolerance by inactivating the carbon catabolite repression determinant CcpA in Streptococcus gordonii. Journal of Antimicrobial Chemotherapy 59(4) pp. 607-615. [DOI] [Web of Science] [Pubmed]
Bizzini A., Majcherczyk P., Beggah-Möller S., Soldo B., Entenza J.M., Gaillard M., Moreillon P., Lazarevic V., 2007. Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii. Microbiology 153(Pt 2) pp. 490-498. [DOI] [Web of Science] [Pubmed]
Haenni M., Moreillon P., Lazarevic V., 2007. Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii. Antimicrobial Agents and Chemotherapy 51(8) pp. 2774-2783. [DOI] [Web of Science] [Pubmed]
Heying R., van de Gevel J., Que Y.A., Moreillon P., Beekhuizen H., 2007. Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells. Thrombosis and haemostasis 97(4) pp. 617-26. [DOI] [Web of Science] [Pubmed]
Moreillon P., Wilson W.R., Leclercq R., Entenza J.M., 2007. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 51(5) pp. 1661-1665. [DOI] [Web of Science] [Pubmed]
Panchaud A., Widmer E., Kussmann M., Moreillon P., Affolter M., 2007. Mass spectrometry as a rapid and powerful alternative to antibodies for detecting LPXTG wall-associated proteins of Staphylococcus aureus. International Journal of Mass Spectrometry 268(2-3) pp. 234-243. [DOI] [Web of Science]
Vankerckhoven V., Moreillon P., Piu S., Giddey M., Huys G., Vancanneyt M., Goossens H., Entenza J.M., 2007. Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. Journal of Medical Microbiology 56(8) pp. 1017-1024. [DOI] [Web of Science] [Pubmed]
Aellen S., Que Y.A., Guignard B., Haenni M., Moreillon P., 2006. Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA. Antimicrobial Agents and Chemotherapy 50(6) pp. 1913-1920. [DOI] [Web of Science] [Pubmed]
Bizzini A., Beggah-Möller S., Moreillon P., Entenza J.M., 2006. Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis. FEMS Immunology and Medical Microbiology 48(3) pp. 419-423. [DOI] [Web of Science] [Pubmed]
Giannoni E., Moreillon P., Cotting J., Moessinger A., Bille J., Décosterd L., Zanetti G., Majcherczyk P., Bugnon D., 2006. Prospective determination of plasma imipenem concentrations in critically ill children. Antimicrobial Agents and Chemotherapy 50(7) pp. 2563-2568. [DOI] [Web of Science] [Pubmed]
Haenni M., Majcherczyk P.A., Barblan J.L., Moreillon P., 2006. Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii. Antimicrobial Agents and Chemotherapy 50(12) pp. 4062-4069. [DOI] [Web of Science] [Pubmed]
Moreillon P., Bizzini A., Que Y. A., 2006. Infective endocarditis in the elderly. pp. 1749-1762 in Patty J.M.S., Sinclair A.J., Morley J.E. (eds.) Principles and Practice of Geriatric Medicine. 4th ed., John Wiley & Sons.
Panchaud A., Guillaume E., Affolter M., Robert F., Moreillon P., Kussmann M., 2006. Combining protein identification and quantification: C-terminal isotope-coded tagging using sulfanilic acid. Rapid Communications in Mass Spectrometry 20(10) pp. 1585-1594. [DOI] [Web of Science] [Pubmed]
Que Y.A., Moreillon P., Francioli P., 2006. L'endocardite en pratique ambulatoire [Infective endocarditis and outpatient practice]. Revue Médicale Suisse 2(60) pp. 903-6, 908-11. [Pubmed]
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2006. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. Journal of Antimicrobial Chemotherapy 58(6) pp. 1208-1214. [DOI] [Web of Science] [Pubmed]
Widmer E., Que Y.A., Entenza J.M., Moreillon P., 2006. New concepts in the pathophysiology of infective endocarditis. Current Infectious Disease Reports 8(4) pp. 271-279. [DOI] [Pubmed]
2005
Entenza J.M., Loeffler J.M., Grandgirard D., Fischetti V.A., Moreillon P., 2005. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrobial Agents and Chemotherapy 49(11) pp. 4789-4792. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Moreillon P., Senn M.M., Kormanec J., Dunman P.M., Berger-Bächi B., Projan S., Bischoff M., 2005. Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infection and Immunity 73(2) pp. 990-998. [DOI] [Web of Science] [Pubmed]
Guignard B., Entenza J.M., Moreillon P., 2005. Beta-lactams against methicillin-resistant Staphylococcus aureus. Current Opinion in Pharmacology 5(5) pp. 479-489. [DOI] [Web of Science] [Pubmed]
Moreillon P., Que Y. A., Glauser M. P., 2005. Staphylococcus aureus (Including Staphylococcal Toxic Shock). pp. 2321-2351 in Mandell G. L., Bennett J. E., Dolin R. (eds.) Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 6th ed, Churchill Livingstone, New York.
Que Y.A., Haefliger J.A., Piroth L., François P., Widmer E., Entenza J.M., Sinha B., Herrmann M., Francioli P., Vaudaux P. et al., 2005. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. Journal of Experimental Medicine 201(10) pp. 1627-1635. [DOI] [Web of Science] [Pubmed]
Rigoulay C., Entenza J.M., Halpern D., Widmer E., Moreillon P., Poquet I., Gruss A., 2005. Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infection and Immunity 73(1) pp. 563-572. [DOI] [Web of Science] [Pubmed]
Suarez M., Haenni M., Canarelli S., Fisch F., Chodanowski P., Servis C., Michielin O., Freitag R., Moreillon P., Mermod N., 2005. Structure-function characterization and optimization of a plant-derived antibacterial peptide. Antimicrobial Agents and Chemotherapy 49(9) pp. 3847-3857. [DOI] [Web of Science] [Pubmed]
2004
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 2004. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrobial Agents and Chemotherapy 48(1) pp. 86-92. [DOI] [Web of Science] [Pubmed]
Majcherczyk P. A., Moreillon P., 2004. Inflammation and host defense. pp. 183-200 in Tuomanen E. I., Mitchell T. J., Morison D. A., Spratt B. G. (eds.) The Pneumococcus. ASM Press, Washington DC.
Moreillon P., Que Y.A., 2004. Infective endocarditis. Lancet 363(9403) pp. 139-149. [DOI] [Web of Science] [Pubmed]
Que Y.A., Oddo M., Liaudet L., Moreillon P., 2004. Endocardite infectieuse: mise au point [Infective endocarditis: update]. Revue Médicale de la Suisse Romande 124(6) pp. 341-346. [Pubmed]
2003
Cottagnoud P., Gerber C.M., Majcherczyk P.A., Acosta F., Cottagnoud M., Neftel K., Moreillon P., Täuber M.G., 2003. The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis. Infection and Immunity 71(6) pp. 3663-3666. [DOI] [Web of Science] [Pubmed]
Loeliger B., Caldelari I., Bizzini A., Stutzmann Meier P., Majcherczyk P.A., Moreillon P., 2003. Antibiotic-dependent correlation between drug-induced killing and loss of luminescence in Streptococcus gordonii expressing luciferase. Microbial Drug Resistance 9(2) pp. 123-131. [DOI] [Web of Science] [Pubmed]
Marchetti O., Moreillon P., Entenza J.M., Vouillamoz J., Glauser M.P., Bille J., Sanglard D., 2003. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrobial Agents and Chemotherapy 47(5) pp. 1565-1570. [DOI] [Web of Science] [Pubmed]
Moreillon P., 2003. Endocarditis and endarteritis. in Cohen J., Powderly W.G. (eds.) Infectious Diseases. 2nd edition, Mosby, Edinburgh.
Moreillon P., Majcherczyk P.A., 2003. Proinflammatory activity of cell-wall constituents from gram-positive bacteria. Scandinavian Journal of Infectious Diseases 35(9) pp. 632-641. [DOI] [Web of Science] [Pubmed]
Suarez M., Entenza J.M., Doerries C., Meyer E., Bourquin L., Sutherland J., Marison I., Moreillon P., Mermod N., 2003. Expression of a plant-derived peptide harboring water-cleaning and antimicrobial activities. Biotechnology and Bioengineering 81(1) pp. 13-20. [DOI] [Web of Science] [Pubmed]
Weber J.R., Moreillon P., Tuomanen E.I., 2003. Innate sensors for Gram-positive bacteria. Current Opinion in Immunology 15(4) pp. 408-415. [DOI] [Web of Science] [Pubmed]
2002
Blanc D.S., Pittet D., Ruef C., Widmer A.F., Mühlemann K., Petignat C., Harbarth S., Auckenthaler R., Bille J., Frei R. et al., 2002. Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. Clinical Microbiology and Infection 8(7) pp. 419-426. [DOI] [Web of Science] [Pubmed]
Bugnon D., Giannoni E., Majcherczyk P., Glauser M.P., Moreillon P., 2002. Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitro. Antimicrobial Agents and Chemotherapy 46(11) pp. 3654-3656. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Hohl P., Heinze-Krauss I., Glauser M.P., Moreillon P., 2002. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Antimicrobial Agents and Chemotherapy 46(1) pp. 171-177. [DOI] [Web of Science] [Pubmed]
Majcherczyk P.A., Moreillon P., Decosterd L.A., Sanglard D., Bille J., Glauser M.P., Marchetti O., 2002. Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 28(3-4) pp. 645-651. [DOI] [Web of Science] [Pubmed]
Moreillon P, Entenza JM, 2002. Résistance, virulence et fitness de Staphylococcus aureus. pp. 109-126 in Infection à l'hôpital: 2ème Journée Maurice Rapin - Aventis. Pneumocoques, staphylocoques actualités. Laboratoires Aventis.
Moreillon P., Dargère S., Piroth L., Entenza J. M., 2002. Prophylaxie de l'endocardite infectieuse : apport du modèle expérimental. Médecine et Maladies Infectieuses 32(11) pp. 605-612. [DOI] [Web of Science]
Moreillon P., Potin M., 2002. Traitments antibiotiques simplifies : l'exemple des infections des voies respiratoires supérieures. Médecine et Hygiène 60(2388) pp. 804-808.
Moreillon P., Que Y.A., Bayer A.S., 2002. Pathogenesis of streptococcal and staphylococcal endocarditis. Infectious Disease Clinics of North America 16(2) pp. 297-318. [DOI] [Web of Science] [Pubmed]
2001
Bochud P.Y., Calandra T., Moreillon P., Baumgartner J.D., Yersin B., 2001. Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis media. European Journal of Clinical Microbiology and Infectious Diseases 20(2) pp. 136-137. [DOI] [Web of Science] [Pubmed]
Cottagnoud P., Entenza J.M., Cottagnoud M., Que Y.A., Moreillon P., Taüber M.G., 2001. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiology 1 p. 9. [Document] [Pubmed]
Marchetti O., Majcherczyk P.A., Glauser M.P., Bille J., Moreillon P., Sanglard D., 2001. Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles. Antimicrobial Agents and Chemotherapy 45(3) pp. 696-700. [DOI] [Web of Science] [Pubmed]
Moreillon P., 2001. Apport des modèles expérimentaux: associations Synercid et beta-lactamines. Presse Médicale 30(25 Pt 2) pp. X-XIV. [Web of Science] [Pubmed]
Moreillon P., Entenza J.M., 2001. Antibiotic resistance: learning from animal feeds and animal experimentation. Clinical Microbiology and Infection 7(Suppl. 5) pp. 13-18. [DOI] [Web of Science] [Pubmed]
Que Y.A., François P., Haefliger J.A., Entenza J.M., Vaudaux P., Moreillon P., 2001. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infection and Immunity 69(10) pp. 6296-6302. [DOI] [Web of Science] [Pubmed]
Stutzmann Meier P., Entenza J.M., Vaudaux P., Francioli P., Glauser M.P., Moreillon P., 2001. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infection and Immunity 69(2) pp. 657-664. [DOI] [Pubmed]
2000
Blanc D.S., Bañuls A.L., Hauser P.M., Moreillon P., Francioli P., Tibayrenc M., Swiss MRSA Group, 2000. Methicillin-resistant Staphylococcus aureus: phylogenetic relatedness between European epidemic clones and Swiss sporadic strains. Microbial Drug Resistance 6(3) pp. 231-238. [DOI] [Web of Science] [Pubmed]
Caldelari I., Loeliger B., Langen H., Glauser M.P., Moreillon P., 2000. Deregulation of the arginine deiminase (arc) operon in penicillin-tolerant mutants of Streptococcus gordonii. Antimicrobial Agents and Chemotherapy 44(10) pp. 2802-2810. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Foster T.J., Ni Eidhin D., Vaudaux P., Francioli P., Moreillon P., 2000. Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infection and Immunity 68(9) pp. 5443-5446. [DOI] [Web of Science] [Pubmed]
Marchetti O., Entenza J.M., Sanglard D., Bille J., Glauser M.P., Moreillon P., 2000. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrobial Agents and Chemotherapy 44(11) pp. 2932-2938. [DOI] [Web of Science] [Pubmed]
Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D., 2000. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44(9) pp. 2373-2381. [DOI] [Web of Science] [Pubmed]
Moreillon P., 2000. Moyens de défense des bactéries. Revue Médicale de la Suisse Romande 120(8) pp. 641-650. [Pubmed]
Moreillon P., 2000. Resistance to macrolides-lincosamides-streptogramins and ketolides in staphylococci and streptococci, and new therapeutic strategies. pp. 197-207 in Zinner S.H., Young L.S., Acar J.F., Ortiz-Neu C. (eds.) New considerations for macrolides, azalides, streptogramines, and ketolides. Infectious disease and therapy 23. Marcel Dekker, New York.
Moreillon P., Majcherczyk P., 2000. Is there still a role for penicillins and cephalosporins in the treatment of bacterial infections? International Journal of Clinical Practice. Supplement 115 pp. 99-105. [Web of Science] [Pubmed]
Moreillon P., Wenger A., Caldelari I., 2000. Résistance aux antibiotiques chez les pneumocoques [Pneumococcal antibiotic resistance]. Revue Médicale de la Suisse Romande 120(8) pp. 651-659. [Pubmed]
Que Y.A., Haefliger J.A., Francioli P., Moreillon P., 2000. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infection and Immunity 68(6) pp. 3516-3522. [DOI] [Web of Science] [Pubmed]
Sinha B., Francois P., Que Y.A., Hussain M., Heilmann C., Moreillon P., Lew D., Krause K.H., Peters G., Herrmann M., 2000. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infection and Immunity 68(12) pp. 6871-6878. [DOI] [Web of Science] [Pubmed]
Stutzmann-Meier P., Moriellon P., 2000. Transfer of Staphylococcus aureus pathogenic genes into less virulent bacteria: a strategy to study virulence in experimental endocarditis. pp. 59-65 in van Dissel J.T., van den Broek P.J. (eds.) Infectious diseases: on the threshold of the 21st century. Boerhaave cursus . Boerhaave Commissie, Leiden.
1999
Blanc D.S., Petignat C., Moreillon P., Entenza J.M., Eisenring M., Kleiber H., Wenger A., Troillet N., Blanc C., Francioli P., 1999. Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence. Clinical Infectious Diseases 29(6) pp. 1512-1518. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Caldelari I., Glauser M.P., Moreillon P., 1999. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. Journal of Antimicrobial Chemotherapy 44(6) pp. 775-786. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1999. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 43(1) pp. 77-84. [Web of Science] [Pubmed]
Majcherczyk P.A., Langen H., Heumann D., Fountoulakis M., Glauser M.P., Moreillon P., 1999. Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity. Journal of Biological Chemistry 274(18) pp. 12537-12543. [DOI] [Web of Science] [Pubmed]
Moreillon P., 1999. Endocarditis and endarteritis. pp. 50.1-50.10 in Armstrong D., Cohen J. (eds.) Infectious Diseases. Mosby, London.
1998
Baumgartner J.D., Moreillon P., 1998. Généralités sur les antibiotiques de type bêtalactame. pp. 733-743 in Schorderet M. (eds.) Pharmacologie: des concepts fondamentaux aux applications thérapeutiques. 3e ed, Frison-Roche; Slatkine, Paris.
Entenza J.M., Marchetti O., Glauser M.P., Moreillon P., 1998. Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis. Antimicrobial Agents and Chemotherapy 42(8) pp. 1889-1894. [Web of Science] [Pubmed]
Glauser M.P., Moreillon P., 1998. Considérations générales sur les antibiotiques. pp. 721-723 in Schorderet M. (eds.) Pharmacologie: des concepts fondamentaux aux applications thérapeutiques. 3e ed., Frison-Roche ; Slatkine, Paris.
Que Y.A., Entenza J.M., Francioli P., Moreillon P., 1998. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 177(1) pp. 146-154. [DOI] [Web of Science] [Pubmed]
1997
Entenza J.M., Caldelari I., Glauser M.P., Francioli P., Moreillon P., 1997. Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii. Journal of Infectious Diseases 175(1) pp. 70-76. [DOI] [Web of Science] [Pubmed]
1996
Blanc D.S., Petignat C., Moreillon P., Wenger A., Bille J., Francioli P., 1996. Quantitative antibiogram as a typing method for the prospective epidemiological surveillance and control of MRSA: comparison with molecular typing. Infection Control and Hospital Epidemiology 17(10) pp. 654-659. [DOI] [Web of Science] [Pubmed]
Moreillon P., 1996. Peptidoglycane et protéines de liaison à la pénicilline chez les Staphylococcus aureus résistant à la méticilline. pp. 15-23 in Étienne J., Goldstein F.W. (eds.) Les staphylocoques dorés résistants à la méticilline: aspects fondamentaux et cliniques. RPR Bellon, Paris.
Moreillon P., Wenger A., 1996. Résistance aux antibiotiques chez les pneumocoques. Schweizerische Medizinische Wochenschrift 126(7) pp. 255-263. [Web of Science] [Pubmed]
Vermot D., Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1996. Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 40(3) pp. 809-811. [Web of Science] [Pubmed]
1995
Entenza J.M., Drugeon H., Glauser M.P., Moreillon P., 1995. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrobial Agents and Chemotherapy 39(7) pp. 1419-1424. [Web of Science] [Pubmed]
Francioli P., Blanc D., Moreillon P., 1995. Role of the environment in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA). pp. 109-131 in Brun-Buisson C. (eds.) Methicillin resistant staphylococci. Maurice Rapin Colloquia 4. Flammarion Medecine-Sciences, Paris.
L'Hériteau F., Entenza J.M., Lacassin F., Leport C., Glauser M.P., Moreillon P., 1995. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrobial Agents and Chemotherapy 39(7) pp. 1425-1429. [Web of Science] [Pubmed]
Moreillon P., 1995. La résistance bactérienne aux antibiotiques. Schweizerische Medizinische Wochenschrift 125(23) pp. 1151-1161. [Web of Science] [Pubmed]
Moreillon P., Entenza J.M., Francioli P., McDevitt D., Foster T.J., François P., Vaudaux P., 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infection and Immunity 63(12) pp. 4738-4743. [Web of Science] [Pubmed]
1994
Entenza J.M., Blatter M., Glauser M.P., Moreillon P., 1994. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci. Antimicrobial Agents and Chemotherapy 38(12) pp. 2683-2688. [Web of Science] [Pubmed]
Entenza J.M., Fluckiger U., Glauser M.P., Moreillon P., 1994. Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Journal of Infectious Diseases 170(1) pp. 100-109. [DOI] [Web of Science] [Pubmed]
Fluckiger U., Francioli P., Blaser J., Glauser M.P., Moreillon P., 1994. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. Journal of Infectious Diseases 169(6) pp. 1397-1400. [DOI] [Web of Science] [Pubmed]
Fluckiger U., Moreillon P., Blaser J., Bickle M., Glauser M.P., Francioli P., 1994. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrobial Agents and Chemotherapy 38(12) pp. 2846-2849. [Web of Science] [Pubmed]
1991
Franciolli M., Bille J., Glauser M.P., Moreillon P., 1991. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 163(3) pp. 514-523. [DOI] [Web of Science] [Pubmed]
Moreillon P., Franciolli M., Cantoni L., Bille J., Glauser M.P., 1991. Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 163(5) pp. 1165-1166. [DOI] [Web of Science] [Pubmed]
1990
Moreillon P., Markiewicz Z., Nachman S., Tomasz A., 1990. Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms. Antimicrobial Agents and Chemotherapy 34(1) pp. 33-39. [Web of Science] [Pubmed]
1988
Moreillon P., Overholser C.D., Malinverni R., Bille J., Glauser M.P., 1988. Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease. Journal of Infectious Diseases 157(5) pp. 990-995. [DOI] [Web of Science] [Pubmed]
Overholser C.D., Moreillon P., Glauser M.P., 1988. Experimental endocarditis following dental extractions in rats with periodontitis. Journal of Oral and Maxillofacial Surgery 46(10) pp. 857-861. [Web of Science] [Pubmed]
Tomasz A., Moreillon P., Pozzi G., 1988. Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae. Journal of Bacteriology 170(12) pp. 5931-5934. [Web of Science] [Pubmed]
1987
Boelaert J.R., van Landuyt H.W., Valcke Y.J., Cantinieaux B., Lornoy W.F., Vanherweghem J.L., Moreillon P., Vandepitte J.M., 08-1987. The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. Journal of Infectious Diseases 156(2) pp. 384-387. [DOI] [Web of Science] [Pubmed]
Overholser C.D., Moreillon P., Glauser M.P., 1987. Experimental bacterial endocarditis after dental extractions in rats with periodontitis. Journal of Infectious Diseases 155(1) pp. 107-112. [DOI] [Pubmed]
1986
Moreillon P., Francioli P., Overholser D., Meylan P., Glauser M.P., 1986. Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. Journal of Infectious Diseases 154(5) pp. 801-807. [DOI] [Web of Science] [Pubmed]
1985
Moreillon P., Broquet P.E., Bille J., Gloor E., Glauser M.P., 1985. Prévalence des maladies infectieuses au Centre hospitalier universitaire vaudois [Prevalence of infectious diseases at the Vaud University Hospital Center]. Schweizerische Medizinische Wochenschrift 115(8) pp. 261-266. [Web of Science] [Pubmed]
1983
Glauser M.P., Bernard J.P., Moreillon P., Francioli P., 1983. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. Journal of Infectious Diseases 147(3) pp. 568-575. [DOI] [Web of Science] [Pubmed]
Moreillon P., Francioli P., Delacrétaz F., Weber J., Glauser M.P., 1983. Les infections endo-artérielles, complications redoutables des infections à salmonelles non typhi [Endarterial infections, redoubtable complications of non-typhi salmonella infections]. Schweizerische Medizinische Wochenschrift 113(51) pp. 1953-1955. [Web of Science] [Pubmed]
Phd thesis
Coelho Veloso T. R., 2014. Towards a system analysis of the early steps of infectious endocarditis pathogenesis. Université de Lausanne, Faculté de biologie et médecine, Entenza J. (dir.).
Fernández Fernández C., 2013. Regulation of the activity of DnaA and its role during the cell cycle of caulobacter crescentus. 138 p., Université de Lausanne, Faculté de biologie et médecine, Collier, J., Moreillon, P. (dir.).
Ythier M., 12-2012. VARIABILITY OF PHENOTYPIC, PROTEOMIC AND TRANSCRIPTOMIC EXPRESSION OF STAPHYLOCOCCUS AUREUS SURFACE ADHESINS. Université de Lausanne, Faculté de biologie et médecine, Moreillon, P. (dir.). [Document]
Chapuis T., 2010. Prospective monitoring of cefepime in intensive care unit adult patients. 11 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.). [Document]
Guy L., 2007. Architectural features of bacterial genomes and their applications. 235 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.).
Panchaud A., 2007. Identification and quantification techniques in mass spectrometry-based proteomics. 258 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.).
Aellen S., 2006. Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of ribosomal RNA. 28 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.). [Document]
Bizzini A., 2006. Molecular mechanisms of penicillin-induced killing and penicillin tolerance in Streptococcus gordonii. 128 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.).
Giannoni E., 2006. Prospective determination of imipenem concentration of the plasma of critically-ill children. 21 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.). [Document]
Haenni M., 2006. Role of penicillin-binding proteins in Streptococcus gordonii. 153 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.).
Guignard B., 2005. Methicillin-resistant Staphylococcus aureus resensitization by protein synthesis inhibitors : proposal for a mechanism. 164 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.).
Kulkarni S., 2005. Interactions between feather-degrading bacteria and an avian host : zebra finches (Taeniopygia guttata). 89 p., Université de Lausanne, Faculté de biologie et médecine, Heeb P. (dir.).
Zimmerli S.C., 2005. Immunology of viral disease, how to curb persistent infection. 108 p., Université de Lausanne, Faculté de biologie et médecine, Moreillon P. (dir.). [Document]
 
 
 
 
 
 
 
Search:
 inside this site:
   
   
 Go
 
rss/atom
share share      print print
Biophore - CH-1015 Lausanne  - Switzerland  -  Tel. +41 21 69256 00  -  Fax +41 21 69256 05
Swiss University